v3.20.2
Condensed Consolidated Interim Balance Sheets - USD ($)
Sep. 30, 2020
Mar. 31, 2020
Current    
Cash and cash equivalents $ 1,350,627 $ 2,269,747
Accounts receivable 657,615 846,964
Prepaid expenses and other receivables (Note 5) 1,671,298 1,632,555
Inventories (Note 6) 890,321 1,059,462
Due from related parties (Note 9(a)) 19,151 17,840
Total Current Assets 4,589,012 5,826,568
Equipment (Note 7) 119,913 154,144
Technology and other assets (Note 4) 1,402,916 1,449,924
Goodwill (Note 3) 11,085,984 11,085,984
Total Assets 17,197,825 18,516,620
Current    
Accounts Payable (Notes 9(b)) 529,618 857,093
Accrued liabilities (Notes 8 and 9(b)) 1,616,625 1,647,656
PPP Loan (Note 8 (c)) 459,912 0
Convertible Loans (Note 8(a) (b)) 3,762,889 2,078,833
Deferred revenue - Contract Liabilities 526,250 616,063
Total Current Liabilities 6,895,294 5,199,645
Shareholders' Equity    
Preferred Stock, par value $0.001; Authorized 10,000,000 (March 31, 2020 - 10,000,000) Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2020 - 1) 0 0
Common Shares, par value $0.001; Authorized - 500,000,000; (March 31, 2020 - 500,000,000) Issued and outstanding 5,009,151 and 117,683 Exchangeable Shares (March 31, 2020 - 5,009,151 and -117,683) 5,126 5,126
Additional paid in capital 85,263,824 84,643,570
Deficit (75,008,568) (71,373,870)
Accumulated other comprehensive income 42,149 42,149
Total Shareholders' Equity 10,302,531 13,316,975
Total Liabilities and Shareholders' Equity $ 17,197,825 $ 18,516,620

Source